The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy research

  • 3


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The biomedical model posits that mental disorders are brain diseases and emphasizes pharmacological treatment to target presumed biological abnormalities. A biologically-focused approach to science, policy, and practice has dominated the American healthcare system for more than three decades. During this time, the use of psychiatric medications has sharply increased and mental disorders have become commonly regarded as brain diseases caused by chemical imbalances that are corrected with disease-specific drugs. However, despite widespread faith in the potential of neuroscience to revolutionize mental health practice, the biomedical model era has been characterized by a broad lack of clinical innovation and poor mental health outcomes. In addition, the biomedical paradigm has profoundly affected clinical psychology via the adoption of drug trial methodology in psychotherapy research. Although this approach has spurred the development of empirically supported psychological treatments for numerous mental disorders, it has neglected treatment process, inhibited treatment innovation and dissemination, and divided the field along scientist and practitioner lines. The neglected biopsychosocial model represents an appealing alternative to the biomedical approach, and an honest and public dialog about the validity and utility of the biomedical paradigm is urgently needed. © 2013 Elsevier Ltd.

Author-supplied keywords

  • *biomedical model
  • *disease model
  • *mental disease
  • New Zealand
  • United States
  • attention deficit disorder
  • brain disease
  • chronicity
  • clinical psychology
  • depression
  • disease association
  • disease severity
  • drug industry
  • drug marketing
  • drug mechanism
  • health care policy
  • human
  • major depression
  • medical research
  • molecular biology
  • national health organization
  • olanzapine
  • patient advocacy
  • perphenazine
  • psychotherapy
  • psychotropic agent
  • quetiapine
  • randomized controlled trial (topic)
  • review
  • risperidone
  • schizophrenia
  • social stigma
  • substance abuse
  • ziprasidone

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

There are no authors.

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free